Why the study?
Does a subxiphoid pericardial window improve survival in patients with malignant pericardial effusion from carcinoma of the bronchus compared to no pericardial window?
Population
21 patients with malignant pericardial effusion from carcinoma of the bronchus treated at the National…
Comparison
Creation of a pericardial window through a… vs No pericardial window created.
Design
Cohort
Follow-up
Up to death (median survival 0.8 to 4 months)
Authors
Loading...
Pericardial window shows no survival benefit in malignant effusion from lung cancer; leaves open its value for symptom relief in prospective studies.
Does a subxiphoid pericardial window improve survival in patients with malignant pericardial effusion from carcinoma of the bronchus compared to no pericardial window?
A subxiphoid pericardial window is a safe and effective procedure for relieving cardiac compression in malignant pericardial effusion, though it does not significantly prolong overall survival, which likely depends on the primary tumor extent.
Shinkai et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: